Carolina Business Review: Panel Interview with BioAgilytix CEO Jim Datin

The Latest News from BioAgilytix

Bioanalysis Zone logo
20 August, 2020

BioAgilytix Announces the Launch of COVIDence™

In this news article, Bioanalysis Zone covers the launch of BioAgilytix’s COVIDence™, a complete COVID-19 workforce testing service for employers.

Read More

19 August, 2020

BioAgilytix Welcomes Marianne Scheel Fjording, Ph.D. to Team as Scientific Officer

Dr. Fjording will be based at BioAgilytix’s European laboratory in Hamburg, Germany and will provide scientific and regulatory oversight to BioAgilytix’s team in the development and implementation of strategies for bioanalytical assay development and regulated assay validation.

Read More

Verdict Medical Devices logo
18 August, 2020

Coronavirus Company News – BioAgiliytix Labs Unveils Workforce Testing Service

This article by Verdict Medical Devices covers the launch of BioAgilytix’s COVIDence™, a complete COVID-19 workforce testing service designed to help US employers reduce the exposure and spread of COVID-19. 

Read More

17 August, 2020

BioAgilytix Labs Launches COVIDence™ Program for COVID-19 Workforce Testing

The end-to-end service handles all aspects of sample collection logistics, testing, and results reporting for employers, providing an easy-to-implement solution to effectively mitigate COVID-19 exposure within their workforces.

Read More

BioAgilytix Diagnostics Logo against a black background
3 August, 2020

BioAgilytix Rebrands Its Cambridge Biomedical Diagnostic Testing Division to BioAgilytix Diagnostics

The new name is reflective of BioAgilytix’s plan, which was set forth following its acquisition of Boston-based Cambridge Biomedical in late 2019, to fully integrate Cambridge Biomedical’s clinical and diagnostic testing capabilities into BioAgilytix’s global service offerings.

Read More

Small PharmTech logo
1 July, 2020

Analytical Assays Determine Biosimilar Product Quality

BioAgilytix supplies its assay expertise to describe the appropriate analytical assays needed to determine and ensure that biosimilar critical quality parameters are on track.

Read More

BioAgilytix leadership - Dr. Chad Briscoe
30 June, 2020

Chad Briscoe, Ph.D. Joins BioAgilytix Leadership Team as Chief Scientific Officer

In this role, Dr. Briscoe will provide scientific and regulatory oversight to BioAgilytix’s global teams with strategic guidance in line with emerging scientific developments.

Read More

Mike Nicholson, Ph.D. Vice President, Operations
25 June, 2020

BioAgilytix Welcomes Mike Nicholson, Ph.D. to Leadership Team as Vice President, Operations

In this role, Dr. Nicholson will oversee bioanalytical operations and scientific team development across BioAgilytix’s laboratories in both the USA and Europe, with particular focus leading the organization’s Gene and Cell Therapy bioanalytical services.

Read More

Bioanalysis Zone logo
24 June, 2020

Customizable COVID-19 Testing Packages Launched to Help Manage and Treat Virus

In this article, Bioanalysis Zone explores the launch of BioAgilytix’s new range of customizable COVID-19 testing packages with commentary from leadership team members.

Read More